Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that members of the management team will present at the following investor and industry conferences in October:

Metadata
Provider: 
Business Wire, Inc.
Retrieved on: 
Monday, September 30, 2019
Information
Tags: 
Science, Biotechnology, Other Science, Research, Health, Genetics, Branches of biology, Biology, Life sciences, Molecular biology, Genetic engineering, Sangamo Therapeutics, Bioethics, Emerging technologies, Genome editing, Gene therapy, Genetically modified organism, Gene editing
Geotags: 
California, United States
⚠ generated by AI ↴
Organisation: 
SANGAMO THERAPEUTICS
Summary
Key Points: 
  • Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that members of the management team will present at the following investor and industry conferences in October:
    Wednesday, Oct 2nd at 3:15 p.m. Pacific Time
    Panel: What does the future hold for gene editing?
  • The presentations will also be available on the Sangamo website after the event.
  • Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation.
  • For more information about Sangamo, visit www.sangamo.com .


Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that members of the management team will present at the following investor and industry conferences in October:

Cell & Gene Meeting on the Mesa 2019

Corporate presentation

Wednesday, Oct 2nd at 3:15 p.m. Pacific Time

Location: Carlsbad, CA

Panel: What does the future hold for gene editing?

Friday, Oct 4th at 9:45 a.m. Pacific Time

Location: Carlsbad, CA

Cantor Global Healthcare Conference 2019

Friday, Oct 4th at 11:15 a.m. Eastern Time

Location: New York, NY

Chardan 3rd Annual Genetic Medicines Conference

Monday, Oct 7th at 8:30 a.m. Eastern Time

Location: New York, NY

Jefferies Gene Therapy/Editing Summit

Tuesday, Oct 8th at 11:15 a.m. Eastern Time

Location: New York, NY

Presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com.

Copyright: 
Copyright Business Wire 2019